As global clinical trial activity continues to normalize from peak pandemic levels, the pharma industry is seeking to improve the efficiency of how such studies are conducted. As a result, competition between both countries and individual sites within these is intensifying.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?